Alzheon, Inc. announced that David Nikodem, Ph.D., has joined its board of directors. Dr. Nikodem is a senior representative of the global healthcare-focused investment firm Ally Bridge Group. Most recently, from 2010 to 2013, Dr. Nikodem served as a Portfolio Manager at Exane Asset Management in Paris, where he managed Exane Equinox, a global healthcare investment fund.
1st Jan change | Capi. | |
---|---|---|
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |